Literature DB >> 15180723

Assessment of health state utilities and quality of life in patients with malignant esophageal Dysphagia.

Stephan M Wildi1, Monty H Cox, Leslie L Clark, Robert Turner, Robert H Hawes, Brenda J Hoffman, Michael B Wallace.   

Abstract

OBJECTIVES: Palliation of terminal conditions such as malignant dysphagia must take into account individual preferences for aggressive or nonaggressive care, with a focus on quality of life. Despite this, there are very few data on patients' preferences for palliative therapy. This study is designed to quantitatively determine individual preferences for palliation of malignant dysphagia using health state utilities (HSU).
METHODS: HSU were measured using three methods: time trade-off (TTO), visual analog scale (VAS), and the EQ-5D. Patients with esophageal cancer were asked to rate their own state of health and of three standardized scenarios of local, regional, and metastatic disease.
RESULTS: Fifty patients with esophageal cancer were enrolled. Using the TTO method, the utilities of their own health state were 0.80 (95% CI 0.59-0.99) for localized, 0.54 (0.37-0.70) for regional, and 0.52 (0.32-0.71) for metastatic cancer showing no significant difference in mean utility scores for the three staging groups. VAS and EQ5D gave statistically similar values to TTO. Patients consistently rated their own utility better than the utility of standardized scenarios with similar stage and prognosis. Independent of their staging, patients with high dysphagia scores rated their utility worse than patients with low dysphagia scores.
CONCLUSIONS: These results confirm the perceived poor state of health of patients with esophageal cancer and are substantially lower than previous estimates in operated patients. Cost-effectiveness models must take into account significant differences between patients' assessment of their own state of health, and that of a "societal" perspective of others with a similar disease. All three methods provided similar estimates. Given the ease of use of VAS and EQ-5D, these methods may be preferable to TTO.

Entities:  

Mesh:

Year:  2004        PMID: 15180723     DOI: 10.1111/j.1572-0241.2004.30166.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

1.  The Stretta procedure versus proton pump inhibitors and laparoscopic Nissen fundoplication in the management of gastroesophageal reflux disease: a cost-effectiveness analysis.

Authors:  Dan Comay; Viviane Adam; Ediardo B da Silveira; Wendy Kennedy; Serge Mayrand; Alan N Barkun
Journal:  Can J Gastroenterol       Date:  2008-06       Impact factor: 3.522

2.  Health-Related Quality of Life Associated with Barrett's Esophagus and Cancer.

Authors:  Norma B Bulamu; Gang Chen; Julie Ratcliffe; Ann Schloite; Tim Bright; David I Watson
Journal:  World J Surg       Date:  2019-06       Impact factor: 3.352

3.  Utility values among glaucoma patients: an impact on the quality of life.

Authors:  V Gupta; G Srinivasan; S S Mei; G Gazzard; R Sihota; K S Kapoor
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

4.  EQ-5D Health Utility Scores: Data from a Comprehensive Canadian Cancer Centre.

Authors:  Hiten Naik; Doris Howell; Susie Su; Xin Qiu; M Catherine Brown; Ashlee Vennettilli; Margaret Irwin; Vivien Pat; Hannah Solomon; Tian Wang; Henrique Hon; Lawson Eng; Mary Mahler; Henry Thai; Valerie Ho; Wei Xu; Soo Jin Seung; Nicole Mittmann; Geoffrey Liu
Journal:  Patient       Date:  2017-02       Impact factor: 3.883

5.  Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer.

Authors:  D J Sher; R B Tishler; D Annino; R S Punglia
Journal:  Ann Oncol       Date:  2009-10-15       Impact factor: 32.976

Review 6.  Health utilities using the EQ-5D in studies of cancer.

Authors:  A Simon Pickard; Caitlyn T Wilke; Hsiang-Wen Lin; Andrew Lloyd
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

7.  Development of the Northwestern Esophageal Quality of Life Scale: A Hybrid Measure for Use Across Esophageal Conditions.

Authors:  Alyse Bedell; Tiffany H Taft; Laurie Keefer; John Pandolfino
Journal:  Am J Gastroenterol       Date:  2016-02-16       Impact factor: 10.864

8.  The cost-effectiveness of food consistency modification with xanthan gum-based Nutilis Clear® in patients with post-stroke dysphagia in Poland.

Authors:  Aleksandra Pelczarska; Michał Jakubczyk; Maciej Niewada
Journal:  BMC Health Serv Res       Date:  2020-06-17       Impact factor: 2.655

9.  Health-related quality of life in patients with esophageal cancer or precancerous lesions assessed by EQ-5D: A multicenter cross-sectional study.

Authors:  Youqing Wang; Jufang Shi; Lingbin Du; Huiyao Huang; Le Wang; Juan Zhu; Huizhang Li; Yana Bai; Xianzhen Liao; Ayan Mao; Guoxiang Liu; Jiansong Ren; Xiaojie Sun; Jiyong Gong; Qi Zhou; Ling Mai; Lin Zhu; Xiaojing Xing; Yuqin Liu; Ying Ren; Bingbing Song; Li Lan; Jinyi Zhou; Peian Lou; Xiaohua Sun; Xiao Qi; Shouling Wu; Wenqiang Wei; Kai Zhang; Min Dai; Wanqing Chen; Jie He
Journal:  Thorac Cancer       Date:  2020-03-04       Impact factor: 3.500

10.  Health-related quality of life of esophageal cancer patients in daily life after treatment: A multicenter cross-sectional study in China.

Authors:  Qian Liu; Hongmei Zeng; Ruyi Xia; Gang Chen; Shuzheng Liu; Zhiyi Zhang; Yuqin Liu; Guizhou Guo; Guohui Song; Yigong Zhu; Xianghong Wu; Bingbing Song; Xianzhen Liao; Yanfang Chen; Wenqiang Wei; Wanqing Chen; Guihua Zhuang
Journal:  Cancer Med       Date:  2018-10-22       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.